# Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Study · id `cardio:ct-nct05577988` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05577988](<https://clinicaltrials.gov/study/NCT05577988>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05577988

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2468 participants.

## Technical summary

Registry record NCT05577988. Randomized; single masking; primary purpose other. Start 2024-06-18 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Phase 3
- Enrolled: 2468 participants (planned count; ClinicalTrials.gov record NCT05577988, source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)
- Started: 2024-06-18 (actual) (ClinicalTrials.gov record NCT05577988, source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT05577988, source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT05577988, source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05577988, source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05577988-2026-01-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome
- Acronym: ADEN
- Condition: MYOCARDIAL INFARCTION
- Intervention (Other): single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Fonds de Dotation ACTION
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Fonds de Dotation ACTION (`cardio:org-fonds-de-dotation-action`)

## Provenance

Content hash: 2ea4b8e92de9cf1cd4c34310ddb7ddcaae102195971aa8af04e0fa03eb1da0a5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
